Update on HLA-B*15:02 allele associated with adverse drug reactions

被引：0
|
作者：
Zhu, Xueting [1 ]
Luo, Guanghua [1 ]
Zheng, Lu [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 3, Clin Med Res Ctr, Changzhou, Peoples R China
来源：
PHARMACOGENOMICS | 2024年 / 25卷 / 02期
关键词：
adverse drug reactions; antiepileptic drug; genetic marker; HLA-B*15:02; review; STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; POLYMERASE-CHAIN-REACTION; HLA CLASS-I; INDUCED MACULOPAPULAR EXANTHEMA; GENETIC-MARKERS; RISK-FACTOR; B LOCUS; CARBAMAZEPINE; HAN;
D O I：
10.2217/pgs-2023-0173
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
HLA alleles, part of the major histocompatibility complex, are strongly associated with adverse drug reactions (ADRs). This review focuses on HLA-B*15:02 and explores its association with ADRs in various ethnic populations and with different drugs, aiming to provide insights into the safe clinical use of drugs and minimize the occurrence of ADRs. Furthermore, the review explores the potential mechanisms by which HLA-B*15:02 may be associated with ADRs, aiming to gain new insights into drug modification and identification of haptens. In addition, it analyzes the frequency of the HLA-B*15:02, genotyping methods, cost-effectiveness and treatment measures for adverse reactions, thereby providing a theoretical basis for formulating clinical treatment plans.
引用
收藏
页码：97 / 111
页数：15
相关论文
共 50 条
  • [21] Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
    Tiwattanon, Kanyawan
    John, Shobana
    Koomdee, Napatrupron
    Jinda, Pimonpan
    Rachanakul, Jiratha
    Jantararoungtong, Thawinee
    Nuntharadthanaphong, Nutthan
    Kloypan, Chiraphat
    Biswas, Mohitosh
    Boongird, Apisit
    Sukasem, Chonlaphat
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] The novel HLA-B*42:02:02 allele identified in a Brazilian family
    Stelet, Vinicius N.
    Cita, Rafael F.
    Mendes, Maristela F.
    Nogueira, Diones P.
    Abdelhay, Eliana
    HLA, 2020, 96 (05) : 638 - 640
  • [23] Novel HLA-B*81:02:02 allele identified in a Saudi individual
    Alburaq, Mohammed
    AlSebaiheen, Farrah
    Alshubaili, Abdullah
    Alghamdi, Mohammed
    Hajeer, Ali H.
    HLA, 2020, 96 (05) : 644 - 645
  • [24] Is HLA-B*13: 02 new a new Null allele?
    Binder, T. M. C.
    Kelsch, R.
    Siebert, N.
    Trojok, P.
    Roth, T.
    Peter, W.
    Schaefer, M.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2017, 44 : 61 - 61
  • [25] Detection of the HLA-B*40:02:03 allele, a variant of HLA-B*40:02:01:01, in a Taiwanese individual
    Yang, Kuo-Liang
    Lin, Py-Yu
    HLA, 2023, 101 (06) : 677 - 678
  • [26] Characterization of a novel HLA-B*40 allele, HLA-B*40:186:02, by cloning and sequencing
    Wang, W. Y.
    Zhang, W.
    Cai, J. H.
    Zhu, F. M.
    Tian, W.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2016, 43 (04) : 240 - 241
  • [27] A novel HLA-B allele, HLA-B*15:399, identified in a Chinese individual
    Yu, H.
    Ji, X.
    Liu, Z.
    Wang, J.
    Chen, Q.
    HLA, 2016, 88 (05) : 264 - 265
  • [28] Identification of a new HLA-B allele, HLA-B*15:300, in a Chinese individual
    Li, W. -X.
    Xia, J. -A.
    Mao, Y.
    Li, G.
    Shen, G.
    HLA, 2016, 87 (03) : 175 - U97
  • [29] Identification of the Novel HLA-B*15:245:02Q Allele in a Chinese Individual
    Xia, Jiaan
    Li, Wangxia
    HLA, 2025, 105 (01)
  • [30] HAPLOTYPE OF HLA-B*13:01/HLA-B*15:02 AND DAPSONE-INDUCED DRUG HYPERSENSITIVITY SYNDROME IN THAI
    Sukasem, Chonlaphat
    Tempark, Therdpong
    Satapornpong, Patompong
    Rerknimitr, Pawinee
    Klaewsongkram, Jettanong
    Tassaneeyakul, Wichittra
    HLA, 2017, 89 (06) : 470 - 471
12345